Robert Wood Johnson Foundation’s Royalty Pharma RPRX Stock Holding History

Robert Wood Johnson Foundation’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-970,151	Closed	-$35M	–	6
2023 Q1	$35M	Hold	970,151	–	–	1.76%	3
2022 Q4	$38.3M	Hold	970,151	–	–	1.71%	3
2022 Q3	$39M	Hold	970,151	–	–	1.85%	3
2022 Q2	$40.8M	Hold	970,151	–	–	1.76%	3
2022 Q1	$37.8M	Hold	970,151	–	–	1.62%	3
2021 Q4	$38.7M	Hold	970,151	–	–	1.71%	3
2021 Q3	$35.1M	Hold	970,151	–	–	1.65%	3
2021 Q2	$39.8M	Hold	970,151	–	–	1.83%	3
2021 Q1	$4.23B	Sell	970,151 -2,988,347	-75%	-$142M	21.59%	3
2020 Q4	$1.98B	Sell	3,958,498 -15,302	-0.4%	-$649K	21.69%	3
2020 Q3	$1.67B	Hold	3,973,800	–	–	20.05%	3
2020 Q2	$1.93B	Buy	+3,973,800	New	+$197M	28.05%	2

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Robert Wood Johnson Foundation's RPRX Position: Q2 2023 in Review

Robert Wood Johnson Foundation sold out of Royalty Pharma (RPRX) in Q2 2023, closing a stake of 970,151 shares — an estimated $35M sold.

Robert Wood Johnson Foundation first reported a position in RPRX in Q2 2020 and held it in 12 quarters. The position peaked at $4.23B in Q1 2021. 325 funds tracked by Wall St. Rank hold RPRX as of Q2 2023.

Robert Wood Johnson Foundation reported no remaining Royalty Pharma position as of Q2 2023 after selling out during the quarter.
Robert Wood Johnson Foundation sold 970,151 Royalty Pharma shares in Q2 2023, an estimated $35M.
Robert Wood Johnson Foundation first reported a position in Royalty Pharma in Q2 2020 and held it in 12 quarters.
Robert Wood Johnson Foundation's Royalty Pharma position peaked at $4.23B in Q1 2021.
325 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2023.

Based on Robert Wood Johnson Foundation's 13F filing for Q2 2023, filed 11 Aug 2023.